Non-alcoholic fatty liver disease [
NAFLD] is frequently diagnosed in daily practice. This condition is represented by a large spectrum of chronic
liver diseases going from pure hepatic steatosis to
cirrhosis and its
complications, including
hepatocellular carcinoma.
NAFLD is usually associated to
glucose and
lipoproteins metabolism increasing the
cardiovascular risk. To
review new advances in the
knowledge of the pathophysiological links between
NAFLD and
cardiovascular risk, evaluation of
cardiovascular risk in this special situation and the different
therapeutics proposed.
Systematic review of the
literature using medical data bases [
Medline] with the following key words
non-alcoholic fatty liver disease, hepatic steatosis,
cardiovascular risk,
metabolic syndrome. We'll
report pathophysiological links between
NAFLD and
cardiovascular risk, propose an evaluation of
cardiovascular risk in this special situation and expose a
therapeutic strategy. The discovery of a
non alcoholic fatty liver disease should
lead to a
cardiovascular risk evaluation